JNH — Jack Nathan Medical Cashflow Statement
0.000.00%
Last trade - 00:00- CA$0.87m
- -CA$1.09m
- CA$8.71m
Annual cashflow statement for Jack Nathan Medical, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.91 | -8.02 | -6.9 | -7.44 | 7.48 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 9.72 | 3.13 | 2.65 | 0.817 | -15.2 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.706 | 0.216 | 1.26 | -0.662 | 0.288 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.809 | -4.34 | -2 | -6.11 | -6.36 |
| Capital Expenditures | -0.5 | -0.951 | -2.59 | -4.09 | -1.18 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.247 | -1.19 | -0.1 | — | 5.63 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.253 | -2.14 | -2.69 | -4.09 | 4.45 |
| Financing Cash Flow Items | -0.352 | -0.191 | 2.27 | 1.53 | 0.68 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8.68 | -0.164 | 5.28 | 11.9 | 1.04 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.69 | -6.62 | 0.398 | 1.61 | -0.867 |